Microlife Microlife
  • Voor de consument
    • BP A7 Touch BT_half_cuff Bloeddrukmeters
    • NC200_front Thermometers
    • BreastPump_BC200-front Baby Care
    • NEB NANObasic_half-acc Ademhalingszorg
    • FH_422 Warmtetherapie
    • WS 200 BT_front Gewicht
    • Microlife WS 80-N half Weight
    • Software_downloads_allg Software
  • Voor de professional
    • WatchBP Office ABI_front_cuff WatchBP Office
    • WatchBP O3 Ambulatory AFIB_front_cuff WatchBP O3
    • WatchBP Home A_front_cuff WatchBP Home
    • Cuff-Ankle Manchetten en onderdelen
    • Software Software
    • PP-In-Use WBP Office_Inter-Arm-Difference Proefplaatsing
  • Klinische Validaties
  • Technologieën
  • Health Magazine
    • icon_heart_blue Bloeddruk
    • icon_Temperature Koorts
    • icon_airway-treatment Luchtwegaandoening
    • icon_even_heat_blue Warmtetherapie
  • Support
    • BP A2 Basic startseite Hulp bij producten
    • Software_downloads_allg Software voor thuisgebruik
    • Software_downloads_WBP Software voor de professional
  • Over Microlife
    • aboutus Over ons
    • Events Nieuws & Events
    • contact Contact
    • History Geschiedenis
  • Developers
NEDERLAND
Nederlands
Europe
  • EUROPE - English
  • CZECHIA - Čeština
  • DANMARK - Dansk
  • DEUTSCHLAND - Deutsch
  • ESPAÑA - Español
  • FRANCE - Français
  • HRVATSKA - Hrvatski
  • ITALIA - Italiano
  • LATVIJA - Latviešu
  • LIETUVA - Lietuvių
  • MAGYARORSZÁG - Magyar
  • NEDERLAND - Nederlands
  • ÖSTERREICH - Deutsch
  • POLSKA - Polski
  • PORTUGAL - Português
  • SCHWEIZ - Deutsch
  • SLOVENSKO - Slovenčina
  • SLOVENIJA - Slovenščina
  • SUOMI - Suomi
  • SCHWEIZ - Français
  • UK - English
  • ΕΛΛΆΔΑ - Ελληνικά
  • БЪЛГАРИЯ - Български
  • СРБИЈА - Српски
  • УКРАЇНА - Українська
  • TÜRKIYE - Türkçe
  • РОССИЯ - Русский
  • БЕЛАРУСЬ - Русский
Asia
  • ASIA PACIFIC - English
  • VIỆT NAM - Tiếng Việt
  • ประเทศไทย - ไทย
  • 中国 - 中文
  • 台灣 - 中文
Middle East and North Africa
  • MENA - Arabic عربى
USA, Latin America
  • US - English
  • AMÉRICA DEL SUR - Español
  • COLOMBIA - Español
  • MÉXICO - Español
Menu
microlife-bloodpressure-measurement-man Flow

Validation of the Microlife BP 3BTO-A oscillometric blood pressure monitoring device according to a modified British Hypertension Society protocol

Home > Voor de professional > Validaties & Klinische studies > Validation of the Microlife BP 3BTO-A oscillometric blood pressure monitoring device according to a modified British Hypertension Society protocol, Cuckson, 2002
Share

Alexandra C. Cuckson, Annemarie Reinders, Husain Shabeeh and Andrew H. Shennan, 2002

Background

The market for devices for the selfmeasurement of blood pressure is growing, and as accuracy is of prime importance, there is increasing pressure for manufacturers to provide evidence of independent testing. Recent reviews have shown that only five automated upper arm devices for selfmeasurement of blood pressure have been recommended for use. We tested the Microlife BP 3BTO-A, a lightweight, upper arm, automated oscillometric device, according to a modified version of the British Hypertension Society protocol and also analysed the computer-generated oscillograms for possible causes of inaccuracy.

Methods

One hundred and twenty-six subjects were recruited from general medical and specialist clinics and from amongst the staff at Guy’s and St Thomas’ Hospital, London, UK. Only 85 of these were included in the final analysis. Nine sequential readings were taken by two trained observers alternating between the mercury sphygmomanometer and the device. The last
seven readings were analysed according to the British Hypertension Society protocol. Modifications to the protocol were: (1) the exclusion of patients whose blood pressure varied by more than 15mmHg between sequential observer readings and (2) limited testing in the low systolic pressure range.

Results

The Microlife achieved a grade A for both systolic and diastolic pressure according to the British Hypertension Society protocol. The mean differences (standard deviation) between the observers and the device were -1.6 (7.7) mmHg and -2.1 (6.3) mmHg for systolic and diastolic blood pressure, respectively, therefore also fulfilling the criteria set by the Association
for the Advancement of Medical Instrumentation. Subanalysis for different pressure ranges showed that the device was less accurate in the high-pressure range (4160/100 mmHg).

Conclusion

The Microlife can be recommended for clinical use in an adult population. 

Click here to download abstract as PDF

Microlife
  • Support
  • Contact
  • Imprint
  • Privacybeleid
  • Gebruiksvoorwaarden
Inloggen
Copyright © 2025 - Microlife Corporation. All rights reserved.